Basic Information
STENOCARE A/S was established in 2017 with the sole purpose of actively participating in Denmark's medical cannabis pilot program. The company has been granted a license by the Danish Medicines Agency to cultivate and produce medical cannabis, and it is authorized to import and distribute medical cannabis to Danish patients. STENOCARE A/S will grow and produce medical cannabis in high-tech indoor climate-controlled rooms, where all conditions affecting plant potency, quality, and uniformity can be controlled. The rooms are fully insulated, ensuring that sunlight, outdoor air, and harmful pests do not impact cultivation.STENOCARE A/S has partnered with leading medical cannabis manufacturer Emerald Health Therapeutics with the aim of importing their finished products into Denmark. STENOCARE aims to collaborate with multiple suppliers to ensure better supply security and offer patients a wider variety of medical cannabis products.